Patients with severe mental illness and hepatitis C virus infection benefit from new pangenotypic direct-acting antivirals: Results of a literature review Luis Gutiérrez-Rojas; Jesús José de la Gándara Martín; Luisa García Buey; Juan I. Uriz Otano; Álvaro Mena; Carlos Roncero;

Coordinated assistance plan for the elimination of hepatitis C virus at the centro de ayuda integral al drogodependiente (CAID (Comprehensive Care Centre for Drug Addicts)) María Luisa Gutiérrez García; Raquel Gómez Perosanz; Juan Manuel Acedo Sanz; Alberto Delgado-Iribarren García-Campero; Itziar Claudio Domínguez; Angela Domenech Gómez-Imaz; Montserrat Pérez Encinas; Inés de la Fuente Hermosín; Aurora Fabero Jimenez; Conrado M. Fernández Rodríguez;

Evaluation of the clinical and economic value of sofosbuvir/velpatasvir (SOF/VEL) in patients with chronic hepatitis C in Spain during the last 5 years Rafael Esteban; Raquel Domínguez-Hernández; Helena Cantero; Miguel Ángel Casado;